baber/WOPTO huggingface dataset:
Patent AU-2018282188-A1 (AU)
Title: Tissue contact interface
Inventor: LOCKE CHRISTOPHER BRIAN
IPC: A61M1/00
Filed: 2018-06-05
Abstract: An apparatus, system, and method for closing an opening through a surface of a tissue site is described. The apparatus includes an apposition layer adapted to be positioned over the opening. The apposition layer is formed from a material having a firmness factor, and has a plurality of holes extending through the apposition layer. The holes form a void space and have a perforation shape factor and a strut angle configured to collapse the apposition layer in a first direction relative to a second direction. A sheet having a plurality of perforations is configured to surround the apposition layer, the sheet having a plurality of perforations. The apposition layer generates a closing force in the first direction that is substantially parallel to the surface of the tissue site to close the opening in response to application of a negative pressure.
Patent AU-2018283289-A1 (AU)
Title: Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof
Inventor: GRECO MICHAEL NICHOLAS
IPC: C07D401/04
Filed: 2018-06-15
Abstract: A pharmaceutical formulation of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(l-methyl-lH-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide (compound 1), in particular methanesulfonic acid salt thereof, and methods of using the pharmaceutical formulation for the treatment or prevention of diseases or medical conditions mediated through mutated forms of epidermal growth factor receptor (EGFR), such as various cancers, are disclosed.
Patent AU-2018303667-A1 (AU)
Title: Systems and methods to improve instrument guidance within an intravenous catheter assembly
Inventor: BURKHOLZ JONATHAN KARL
IPC: A61M39/00
Filed: 2018-07-18
Abstract: A catheter assembly and/or an introducer may include one or more features configured to guide a probe and/or a catheter distally through a septum. The catheter assembly may include a catheter adapter, which may include a distal end, a proximal end, and a lumen extending there between, and a septum disposed within the lumen. The septum may include a proximal surface that is tapered inwardly in a distal direction such that the proximal surface of the septum is configured to guide the probe and/or the catheter distally through the septum. The catheter assembly may be configured to receive an introducer, which may include an introducer element. A proximal end of the introducer element may include another proximal surface that is tapered inwardly in the distal direction such that the other proximal surface is configured to guide the probe or the catheter distally through the septum.
Patent AU-2018323938-A1 (AU)
Title: Improved methods and apparatus for hulling crops
Inventor: FOROUTANALIABAD AHMED
IPC: B02B3/04
Filed: 2018-08-27
Abstract: Improved methods and apparatus for dry hulling or dry peeling harvested crops, particularly pistachio nuts, are disclosed. The methods and apparatus of the present invention provide crop harvesting with great efficiency resulting in consistently high percentages of hulled or peeled crops and low percentages of nut breakage, without increasing processing times regardless of the sizes of the crops being hulled or peeled. The methods and apparatus of the present invention also provide for a relatively small overall machine footprint, plus easy and efficient removal and replacement of the impingement drum to accommodate for different drum speeds, different crop sizes, different bolt patterns, different bolt sizes, and other variations allowing embodiments of the invention to be used on a wide range of nuts and vegetables of different varieties, sizes and shapes.
Patent AU-2018351990-A1 (AU)
Title: Method to track SSL session states for SSL optimization of SaaS based applications
Inventor: BHAT AKSHATA
IPC: H04L29/06
Filed: 2018-10-09
Abstract: Described embodiments provide systems and methods for initiating establishment of a connection. The system may include a device intermediary between a client and a server. The device may determine at least one server name indicator (SNI) for an application executing on the client and having a secure session established with the server. The device may determine, for each domain name corresponding to the at least one SNI, a session timeout value for the corresponding domain name. The device may send a message to the client according to each session timeout value, to cause the client to initiate establishment of a connection for the corresponding domain name using the secure session.
Patent AU-2018354011-A1 (AU)
Title: Transistor having low capacitance field plate structure
Inventor: MACDONALD CHRISTOPHER J
IPC: H01L29/20
Filed: 2018-10-04
Abstract: A Field Effect Transistor (FET) having a source, drain, and gate disposed laterally along a surface of a semiconductor and a field plate structure: having one end connected to the source; and having a second end disposed between the gate and the drain and separated from the drain by a gap (37). A dielectric structure (30) is disposed over the semiconductor, having: a first portion disposed under the second end of the field plate structure; and, a second, thinner portion under the gap.
Patent AU-2018359962-A1 (AU)
Title: Botulinum toxin formulations and methods of use thereof in plantar fasciitis with extended duration of effect
Inventor: RUBIO ROMAN
IPC: C07K14/33
Filed: 2018-11-05
Abstract: This invention relates to injectable and transdermal compositions comprising botulinum toxin and their methods of use in administering botulinum toxin to treat or manage plantar fasciitis, a disorder related thereto, or a symptom thereof. The injectable and transdermal compositions and methods in which these compositions are used provide advantageous treatments which result in fast onset, higher responder rates, and/or long duration of effect, for example, a duration of effect for over six months and/or a reduction in plantar fasciitis pain by at least 50% maintained through week 8 following treatment. The topical compositions and methods provide desirable, less painful, treatment alternatives.
Patent AU-2018361481-A1 (AU)
Title: Drug delivery systems and methods comprising polysialic acid and/or other polymers
Inventor: ALONSO FERNANDEZ MARÍA JOSÉ
IPC: A61K31/337
Filed: 2018-11-02
Abstract: The present invention generally relates to particles, including nanocapsules or other nanoentities, comprising a polymer such as polysialic acid. The particles are able to access the interior of the cells, and/or to procure the intracellular release of the associated drugs. In 5 one aspect, the present invention is directed to nanocapsules or other entities having an exterior or surface comprising a polymer such as polysialic acid. In some cases, targeting moieties such as Lyp-1 or tLyp-1 peptide are bonded to the polymer, e.g., using aminoalkyl (C
Patent AU-2018369242-A1 (AU)
Title: Configuration of the initial active bandwidth part for initial network access
Inventor: ABDOLI JAVAD
IPC: H04W72/04
Filed: 2018-11-15
Abstract: Methods and devices for configuring an initial active downlink bandwidth part as part of an initial access procedure are provided. In one provided method, a base station broadcasts a synchronization signal block (SSB) that includes a control resource set (CORESET) configuration index. The CORESET configuration index is one of a plurality of CORESET configuration indexes, each CORESET configuration index being associated with a respective configuration of a CORESET. Each configuration includes a CORESET frequency size, a CORESET time duration, and a frequency offset of the CORESET with respect to the SSB selected from a set of predefined frequency offsets. The initial active downlink bandwidth part is defined as having the same frequency location and bandwidth as the CORESET. The base station transmits, as part of a physical downlink control channel (PDCCH) within the CORESET, information indicating scheduling of remaining minimum system information (RMSI) in a physical downlink shared channel (PDSCH).
Patent AU-2018371372-A1 (AU)
Title: Image processing device and method
Inventor: TSUKUBA TAKESHI
IPC: H04N19/60
Filed: 2018-11-12
Abstract: The present invention relates to an image processing device and a method that make it possible to minimize increases in the memory capacity required for an orthogonal transformation and an inverse orthogonal transformation. A partial matrix constituting part of a transformation matrix is used to derive said transformation matrix, the derived transformation matrix is used to perform an orthogonal transformation of the predicted residual of an image, the predicted residual is subjected to an orthogonal transformation and coefficient data thus obtained is encrypted, and a bit stream is generated. The present invention can be applied, for example, to an image processing device, an image encoding device, an image decoding device, or the like.
Patent AU-2018375426-A1 (AU)
Title: Oral care compositions
Inventor: PAN GUISHENG
IPC: A61Q11/00
Filed: 2018-11-29
Abstract: Compounds and methods for preparing and using the compounds are disclosed herein. The method for preparing the compounds may include contacting a metal ion or salt thereof with an alkali metal polyphosphate salt in an aqueous medium. The method may also include adding a base to increase a pH of the aqueous medium.
Patent AU-2018387255-A1 (AU)
Title: Treatment for inflammatory disease
Inventor: FRYKNÄS MÅRTEN
IPC: A61P37/00
Filed: 2018-12-19
Abstract: The invention provides mebendazole for use in the treatment or prophylaxis of a chronic inflammatory disease, and in particular wherein the chronic inflammatory disease is an autoimmune disease, for example sarcoidosis, systemic lupus erythematosus (SLE), Huntington's disease, end stage renal disease, systemic sclerosis (also called scleroderma), myositis, diabetes type 1, multiple sclerosis, Sjögren's syndrome, rheumatoid arthritis, psoriasis, primary biliary cirrhosis, autoimmune hepatitis, Graves' disease, Addison's disease, tuberculosis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, Alzheimer's disease and coeliac disease. A method for the treatment or prophylaxis of a chronic inflammatory disease, comprising administering an effective amount of a mebendazole or a pharmaceutical composition of mebendazole is also provided. The use of mebendazole for the manufacture of a medicament for the treatment of a chronic inflammatory disease is also provided.
Patent AU-2018399144-A1 (AU)
Title: Assembly for dispensing liquids
Inventor: TURNER JEREMY
IPC: B01F13/00
Filed: 2018-12-21
Abstract: An assembly (2) for dispensing liquids comprises: • a base member (8); • a cap (4) on the base member (8); and • a dispensing capsule (6) in the base member (8) and covered by the cap (4). The dispensing capsule (6) comprises: • a capsule body (7) having a first end (16) and a second end (18); • at least one wall (20) defining a first cavity (38) within the capsule body, the first cavity (38) having a first opening at the first end (16) of the capsule body; • at least one wall (22) defining a second cavity (40) within the capsule body, the second cavity (40) having a second opening at the first end (16) of the capsule body; • the first opening and the second opening provided with a seal member (64) which seals the first cavity (38) and the second cavity (40). The walls of the first cavity and the second cavity are collapsible if pressure is applied to the cavities from the second end (18) of the capsule body.
Patent AU-2018453854-A1 (AU)
Title: Membrane for separation of stem cells from biological samples, production process of said membrane, and process and device for separation, comprising said membrane
Inventor: ARKO ZORAN
IPC: B01D39/16
Filed: 2018-12-20
Abstract: The subject of the invention is a membrane for separation of target stem cells from biological samples, more precisely from a single-cell suspension that was prepared from a biological sample. As a result, sterile target stem cells are obtained in physiological buffer. The membrane of the invention consists of a 3D carrier structure made of at least one layer of biocompatible polymer with specific pore size, as a carrier material, and covalently bound target molecules on its surface and/or in the pores. These target molecules are preferably target antibodies, which recognize characteristic antigens that are bound on the surface of the target stem cells and thus bind the target stem cells to the membrane. Target molecules can be either directly bound to the surface and/or in the pores of the carrier structure or are bound to the surface and/or in the pores of the carrier structure through specific functionalized nanoparticles, which are bound to or embedded into the 3D carrier structure of the membrane. In addition, the present invention includes the membrane production process as well as the process and device for the separation of target stem cells from a biological sample, which includes the above membrane as a constituent part.
Patent WO-2019183683-A1 (WO)
Title: Diagnostic and prognostic methods for estrogen-induced cancers
Inventor: TANWAR PRADEEP S
IPC: G01N33/573
Filed: 2019-03-29
Abstract: Provided herein are methods for detecting an estrogen-induced cancer in a subject, for identifying a subject at risk of developing an estrogen-induced cancer and for determining or predicting prognosis for a subject with an estrogen-induced cancer. The methods of the disclosure comprise determining the level of expression of ALPPL2 in a biological sample, typically a blood sample, obtained from a subject.
Patent AU-2019201645-A1 (AU)
Title: High surface area layered double hydroxides
Inventor: O'HARE DERMOT
IPC: C01F7/784
Filed: 2019-03-11
Abstract: HIGH SURFACE AREA LAYERED DOUBLE HYDROXIDES Abstract Layered double hydroxides having a high surface area (at least 125 m 2 /g) and the formula (I) wherein M and M' are different and each is a charged metal cation (and must be present), z= 1 or 2; y = 3 or 4, 0<x<0.9, b is 0 to 10, c = 0 to 10, X is an anion, n is the charge on the anion, and a = z(1-x)+xy-2; AMO-solvent is aqueous miscible organic solvent, may be prepared by a method which comprises a) precipitating a layered double hydroxide having the formula [M1 xM'y"x(OH)2](X"-)a/nbH20 wherein M, M', z, y, x, a, b and X are as defined above from a solution containing the cations of the metals M and M' and the anion X"-; b) ageing the layered double hydroxide precipitate obtained in step a) in the original solution; c) collecting, then washing the layered double hydroxide precipitate; d) dispersing the wet layered double hydroxide in an AMO solvent so as to produce a slurry of the layered double hydroxide in the solvent; e) maintaining the dispersion obtained in step d); and f) recovering and drying the layered double hydroxide. The high surface area products have low particle size and are particularly suitable for use as catalysts, catalyst supports, sorbents and coatings.
Patent AU-2019206053-A1 (AU)
Title: Total ankle replacement prosthesis
Inventor: TERRILL LANCE
IPC: A61F2/42
Filed: 2019-07-17
Abstract: A total ankle replacement prosthesis may comprise a tibial implant (100), a talar implant (300), and an intermediate implant (200). The intermediate implant (200) may fixedly attach to the tibial implant (100) and may articulate with respect to the talar implant (300). The intermediate implant (200) may have unequal front and back angular extent, so as to discourage a particular direction of subluxation, and a kit may be provided containing various such intermediate implants (200). Various features may be provided in regard to dovetails (122, 124, 126, 222, 224, 226), fins (130), recesses (170, 270), the placement of fins (130) and pegs (142, 144, 342, 344), and the shape of the perimeter of the tibial implant (100). Recesses (170, 270) may allow a surgical blade to slice a latch (260) off of an already-installed intermediate implant (200), in order to allow its removal from the tibial implant (100).
Patent AU-2019227872-A1 (AU)
Title: Two stage methods for processing adhesives and related compositions
Inventor: BARTHOLOMEW ERIC L
IPC: B29C35/08
Filed: 2019-09-10
Abstract: Methods for forming melt processable, actinic radiation polymerizable and crosslinkable adhesives are described. In certain versions, the adhesives or pre-adhesive compositions include two initiators and are polymerized and/or crosslinked by exposure to actinic radiation such as UV light or electron beam radiation. Also described are pre-adhesive compositions including polymerizable monomers, articles including the adhesives, and various methods and systems related to the adhesives and their application. In addition, various apparatuses are described for polymerizing or crosslinking the compositions. Page 40 of 40 11673462 1 (GHMatters)P109455.AU.1
Patent AU-2019231858-A1 (AU)
Title: Methods of administering intravenous meloxicam in a bolus dose
Inventor: MACK RANDALL J
IPC: A61K9/20
Filed: 2019-03-08
Abstract: The present disclosure relates to meloxicam bolus formulations and methods of administering the same intravenously, for treatment of pain, which can provide fast onset of pain relief suitable for management of acute moderate to severe pain.
Patent AU-2019240604-A1 (AU)
Title: A Seat
Inventor: SCARLETT ROYDON MARK
IPC: A61G5/10
Filed: 2019-10-02
Abstract: The invention relates to a seat. It is known to provide seating for disabled users with specific 
postural care requirements where the incline of a seat is adjustable. The incline of some 
existing seats can be adjusted by way of a cable arrangement. However, cables may be 
exposed and can become damaged and need maintenance or replacement. The invention 
aims to go at least some way toward addressing this problem by providing a seat having a 
backrest, a base for receiving the posterior of a human user, and an incline adjuster. The 
incline adjuster has a shaft, a lever, a follower, and a rack. The shaft is moveable to swing 
the lever to cause the follower into or out of locking engagement with the rack, the 
arrangement being such that when the follower is in the unlocked disposition the rack can 
move to adjust the incline of the backrest and base.
1/4 
Figure 1 
1 
2 
3 
6 
4 
v 8 
21 20 7 5
Patent AU-2019250248-A1 (AU)
Title: Apparatus for tightening threaded fasteners
Inventor: KOPPENHOEFER PETER
IPC: B25B21/00
Filed: 2019-10-18
Abstract: Abstract According to a first aspect of the invention we provide an automatic reaction pawl assembly ("ARPA") which includes; a shaft assembly; a pawl fixed rotatably relative to the shaft assembly; and a torsion lever torsionally coupled with the paw) about the shaft assembly. Advantageously the ARPA enhances belting efficiency, increases torque accuracy and maximises operator safety. Torsion springs of the shaft assembly overcome a housing spring and automatically disengage the pawl from a ratchet wheel. The pawl releases without advancing the fastener, touching the tool or raising the hydraulic pressure beyond an intended torque value. This allows for hands free operation of one or more tools. During SWULTORC(R) the operator no longer needs to determine which tool; is locked on to its fastener. 203 202 205 Fig 22 Fi.2420 Fig. 23 208 201Fig. Fig.252 Fig. 26
Patent AU-2019252418-A1 (AU)
Title: Harmonization of transform-based quantization and dynamic range adjustment scale derivation in video coding
Inventor: RAMASUBRAMONIAN ADARSH KRISHNAN
IPC: H04N19/186
Filed: 2019-04-11
Abstract: Techniques for decoding video data include determining a picture quantization parameter (QP) value of the picture of video data, determining an intermediate chroma QP offset value for a chroma QP value based on the picture QP value and a first function based on video characteristics of the picture of video data, determining the chroma QP value with a second function of the intermediate chroma QP offset value, and decoding the picture of video data using the chroma QP value.
Patent AU-2019258956-A1 (AU)
Title: Method for isolating nucleic acids from plant samples
Inventor: O'NEIL DOMINIC
IPC: C12N15/09
Filed: 2019-04-29
Abstract: Provided is a method for isolating nucleic acids from a plant sample comprising (a) preparing a lysed sample wherein preparing comprises (i) lysing a plant sample by mechanically disrupting the plant sample in a lysis solution which comprises at least one chaotropic agent and one or more solid disrupting particles, and (ii) optionally clearing the lysate; (b) contacting the lysed sample with at least one protein precipitating agent and at least one inhibitor removing agent and providing a mixture; (c) obtaining a liquid phase from the mixture; and (d) isolating nucleic acids from the liquid phase. Also provided is a kit for use in such method.
Patent AU-2019293287-A1 (AU)
Title: Compositions for treatment and methods for making and using the same
Inventor: FARVID SHOKOUH
IPC: A01N63/50
Filed: 2019-06-26
Abstract: A detergent composition, a method of making the detergent composition, and a method of use thereof are provided. The detergent composition comprises at least 0.001% by weight of an antimicrobial agent, based on the total weight of the composition; an enzyme; and at least 0.01% by weight of a hydrotrope, based on the total weight of the composition.
Patent AU-2019296855-A1 (AU)
Title: Application of composition of mannuronic diacid in treating diabetes
Inventor: GENG MEIYU
IPC: A61P3/10
Filed: 2019-06-28
Abstract: The present invention relates to an application of a composition of mannuronic diacid in treating diabetes.
Patent AU-2019297083-A1 (AU)
Title: Liquids
Inventor: DE BOER JOHANNES WIETSE
IPC: C08K5/00
Filed: 2019-07-04
Abstract: The present invention concerns the curing and hardening of liquids comprising unsaturated resins, a peroxide and a chelant capable of chelating at least one transition metal ion through three, four, or five nitrogen atoms, which chelants may each optionally be complexed with one or two transition metal ions, typically iron or manganese ions. The invention also provides methods and formulations for making associated compositions, compositions resultant from the curing of such liquids and associated kits comprising two or more compositions physically separated from one another, which may be used to provide curable liquids when mixed..
Patent AU-2019316264-A1 (AU)
Title: Full depth laser ophthalmic surgical system, methods of calibrating the surgical system and treatment methods using the same
Inventor: WANG JENNY
IPC: A61F9/008
Filed: 2019-07-30
Abstract: A full depth ophthalmic surgical system includes a femtosecond laser source and an optical coherence tomographer. The system is capable of performing surgical procedures along the entire length of the eye from the cornea to the retina. In one embodiment, the system uses a removeable focal point extension assembly to extend the reach of the focal point location of the laser beam to the vitreous humor of the eye. In another embodiment, the optical system of the ophthalmic surgical system is optimized to focus the laser beam and imaging light in the vitreous humor of the eye. For procedures performed posterior to the lens, a method for calibrating the full depth ophthalmic surgical system uses the focal zone of the optical coherence tomographer beam as a proxy for the focal zone of the femtosecond laser source to. The system can be used to perform treatment in the vitreous humor, including treating floaters and liquification of the vitreous humor.
Patent AU-2019398339-A1 (AU)
Title: THRβ receptor agonist compound and preparation method and use thereof
Inventor: YU SHANGHAI
IPC: C07F9/30
Filed: 2019-12-12
Abstract: The present invention discloses a compound represented by the following Formula (I) and a pharmaceutically acceptable salt thereof. The compound improves the THRα selectivity while maintaining good THRβ agonistic activity, thereby improving properties of the finished drug. (I)